Numerous Novel Therapeutics for Lupus Nephritis Under Investigation
The landscape of lupus nephritis treatment is poised to change in coming years.
Diagnosis & Disease Information
Lupus Nephritis Flares Still Occur After Dialysis Initiation
Patients are most at risk for flares during the first year of dialysis.
Lupus Nephritis Treatment Consensus and Future Directions
Reviewers discussed new and conventional therapies for lupus nephritis and the prospect of precision medicine.
Update on Lupus Nephritis Management
A review of scientific papers highlights recent advances in lupus nephritis management.
CD19-CAR T Cell Therapy Fast Tracked for Systemic Lupus Erythematosus
CABA-201 is a 4-1BB-containing fully human CD19-CAR T cell therapy.
Death Risk Higher in Older Adults Not Followed Up After Lupus Hospitalization
More than a third of lupus hospitalizations lacked follow-up with a primary care physician or rheumatologist.
Beta-2 Microglobulin Predicts Lupus Nephritis, SLE Disease Activity
Serum beta-2 microglobulin can be used to monitor kidney damage in systemic lupus erythematosus for earlier diagnosis of lupus nephritis.
Childhood-Onset Lupus Nephritis Linked With Adverse Outcomes
Early diagnosis and treatment of childhood-onset systemic lupus erythematosus is important to prevent lupus nephritis outcomes such as end-stage kidney disease.
ACR: Long-Term Safety Demonstrated for Anifrolumab in Lupus
Exposure-adjusted incidence rates of serious adverse events 8.5 versus 11.2 per 100 patient-years for anifrolumab versus placebo
ACR: Low-Dose Hydroxychloroquine Tied to More Hospitalizations for Lupus Flares
Both weight-based and non-weight-based low-dose HCQ associated with increased hospitalizations for SLE
- Loading...
Loading...
Next post in Lupus Nephritis
Loading... 
Loading...